[Effect of D-dimer on the prognosis of patients with aneurysmal subarachnoid hemorrhage based on propensity score matching].

To evaluate the effect of D-dimer on the prognosis of patients with aneurysmal subarachnoid hemorrhage (aSAH). A total of 1 658 patients who were first diagnosed with aSAH in West China Hospital of Sichuan University from December 2013 to June 2019 were retrospectively analyzed. All patients were divided into four groups according to the median and quartiles of D-dimer level, including 415 cases, 414 cases, 414 cases, and 415 cases in groups , , , and , respectively. Groups , , and group were matched by propensity score matching (PSM), and the correlation between D-dimer and each outcome was analyzed by logistic regression. Since there is no general clinical classification standard for D-dimer, this study attempted to reclassify patients into groups q1 (<0.55 mg/L, 94 cases), q2 (0.55-1.65 mg/L, 435 cases), q3 (1.65-5.50 mg/L, 650 cases) and q4 (>5.50 mg/L, 303 cases) based on 1, 3, 5, 10 times of the upper limit of the current clinical reference value. The age of 1 658 aSAH patients were (57±12) years, including 1 068 males and 590 females. After PSM based on the median and quartiles of D-dimer level, there were 318 cases, 318 cases, 251 cases, and 229 cases in groups , , , and , respectively. Compared with group (<1.23 mg/L), the risk of in-hospital infection (=2.14, 95%: 1.47-3.11, <0.001), pneumonia (=2.22, 95%: 1.51-3.28, <0.001), urinary tract infection (=1.75, 95%: 1.12-2.75, =0.014) and intracranial rebleeding (=3.59, 95%: 1.30-9.91, =0.013) group (>4.95 mg/L) was higher. Likewise, the risk of adverse outcomes in group was also higher than that in group , including unfavorable outcome at discharge (=2.12, 95%: 1.43-3.14, <0.001), mortality during hospitalization (=3.03, 95%: 1.26-7.33, =0.014), mortality within 90 days (=2.33, 95%:1.29-4.22, =0.005), mortality within 180 days (=1.92, 95%: 1.12-3.29, =0.018), mortality within 1 year (=2.07, 95%:1.23-3.47, =0.006) and mortality during the longest follow-up period (=1.97, 95%:1.26-3.09, =0.003). After secondary grouping and PSM based on current clinical reference values, there were 90 cases, 87 cases, 90 cases, and 43 cases, respectively in groups q1, q2, q3 and q4. The risk of nosocomial infection (=2.26, 95%: 1.14-4.45, =0.019), blood-borne infection (=8.86, 95%:1.08-72.78, =0.042), poor prognosis at discharge (=4.92, 95%: 2.18-11.07, <0.001), death within 180 days (=3.39, 95%: 1.04-11.08, =0.043), death within 1 year (=3.23, 95%: 1.10-9.49, =0.033), and death within the longest follow-up period (=3.28, 95%: 1.34-8.01, =0.009) was still higher in group q4 than that in group q1. aSAH patients with high D-dimer level have a higher risk of complications and mortality during hospitalization and worse clinical prognosis.